HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

H Yasuhara Selected Research

H Yasuhara Research Topics

Disease

1Wounds and Injuries (Trauma)
10/2013
1Foot Ulcer
09/2008
1Milk Hypersensitivity (Milk Allergy)
01/2008
1Liver Diseases (Liver Disease)
01/2008
1Eosinophilia
01/2008
1Asthma (Bronchial Asthma)
08/2002
1Breast Neoplasms (Breast Cancer)
03/2002
1Thiamine Deficiency
07/2001
1Hyperplasia
02/2001
1Neoplasm Metastasis (Metastasis)
06/2000
1Cardiovascular Diseases (Cardiovascular Disease)
06/2000
1Stomach Neoplasms (Stomach Cancer)
06/2000
1Polyps
01/2000
1Hemorrhage
01/2000
1Peritonitis
01/2000
1Myeloproliferative Disorders (Myeloproliferative Disorder)
01/2000
1Anorexia
01/2000
1Anemia
01/2000
1Intestinal Obstruction (Obstruction, Intestinal)
01/2000

Drug/Important Bio-Agent (IBA)

1Retinal Pigments (Pigments, Visual)IBA
10/2013
1Reactive Oxygen Species (Oxygen Radicals)IBA
10/2013
1Eosinophil Cationic ProteinIBA
01/2008
1Immunoglobulin E (IgE)IBA
01/2008
1casein hydrolysateIBA
01/2008
1Transaminases (Aminotransferases)IBA
01/2008
1montelukast (Singulair)FDA Link
08/2002
1Adrenal Cortex Hormones (Corticosteroids)IBA
08/2002
1Beclomethasone (Beclometasone)FDA Link
08/2002
1Leukotriene Antagonists (Leukotriene Receptor Antagonists)IBA
08/2002
1Liposomes (Liposome)IBA
03/2002
1LipidsIBA
03/2002
1PyrithiamineIBA
07/2001
1Thiamine (Aneurin)FDA Link
07/2001
1Substance PIBA
07/2001
1Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
07/2001
1Angiogenesis InhibitorsIBA
02/2001
1O-(Chloroacetylcarbamoyl)fumagillol (TNP 470)IBA
02/2001
1Fluorouracil (Carac)FDA LinkGeneric
06/2000
1Cisplatin (Platino)FDA LinkGeneric
06/2000
1Platelet-Derived Growth FactorIBA
06/2000
1KanamycinFDA Link
01/2000
1BariumIBA
01/2000
1Isoniazid (Ftivazide)FDA LinkGeneric
01/2000
1Rifampin (Rifampicin)FDA LinkGeneric
01/2000

Therapy/Procedure

2Therapeutics
08/2002 - 01/2000
1Surgical Amputation (Amputations)
09/2008
1Drug Therapy (Chemotherapy)
06/2000
1Laparotomy
01/2000
1Endoscopes
01/2000
1Conservative Treatment
01/2000